The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1519-1523

  Ntaios, G ^a   Vemmou, A ^b   Koroboki, E ^b   Savvari, P ^b   Makaritsis, K ^a   Saliaris, M ^b   Andrikopoulos, G ^b   Vemmos, K ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

Atrial fibrillation; Paroxysmal; Permanent; Persistent; Stroke; Stroke recurrence

Indexed keywords

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL TIME;

ATRIAL FIBRILLATION; PAROXYSMAL; PERMANENT; PERSISTENT; STROKE; STROKE RECURRENCE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84881478744     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.131     Document Type: Article

References (18)

1. S.H. Hohnloser, D. Pajitnev, and J. Pogue Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy J Am Coll Cardiol 50 2007 2156 2161
2. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators J Am Coll Cardiol 35 2000 183 187
3. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators N Engl J Med 323 1990 1505 1511
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
5. L. Friberg, N. Hammar, H. Pettersson, and M. Rosenqvist Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF) Eur Heart J 28 2007 2346 2353
6. P. Petersen, and J. Godtfredsen Embolic complications in paroxysmal atrial fibrillation Stroke 17 1986 622 626
7. J. Staszewski, B. Brodacki, K. Tomczykiewicz, J. Kotowicz, and A. Stepien Strokes in paroxysmal atrial fibrillation have more favorable outcome than in permanent atrial fibrillation Acta Neurol Scand 119 2009 325 331
8. K.N. Vemmos, C.E. Takis, and K. Georgilis The Athens stroke registry: results of a five-year hospital-based study Cerebrovasc Dis 10 2000 133 141
9. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group Stroke 28 1997 2109 2118
10. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
11. C. Marini, S.F. De, and S. Sacco Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study Stroke 36 2005 1115 1119
12. G.Y. Lip Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? Lancet 349 1997 1565 1566
13. H. Sohara, S. Amitani, M. Kurose, and K. Miyahara Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation J Am Coll Cardiol 29 1997 106 112
14. H.P. Adams Jr., Z.G. del, and M.J. Alberts Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke 38 2007 1655 1711
15. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 2008 457 507
16. G. Ntaios, and P. Michel Temporal distribution and magnitude of the vulnerability period around stroke depend on stroke subtype Cerebrovasc Dis 32 2011 246 253
17. A. Chamorro, N. Vila, C. Ascaso, and R. Blanc Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment Arch Neurol 56 1999 1098 1102
18. R. Saxena, S. Lewis, E. Berge, P.A. Sandercock, and P.J. Koudstaal Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial Stroke 32 2001 2333 2337